AMP-activated protein kinase (AMPK) senses changes in the intracellular AMP/ATP ratio, switching off energy-consuming processes and switching on catabolic pathways in response to energy depletion. Here, we show that AMPK down-regulates rRNA synthesis under glucose restriction by phosphorylating the RNA polymerase I (Pol I)-associated transcription factor TIF-IA at a single serine residue (Ser-635). Phosphorylation by AMPK impairs the interaction of TIF-IA with the TBP-containing promoter selectivity factor SL1, thereby precluding the assembly of functional transcription initiation complexes. Mutation of Ser-635 compromises downregulation of Pol I transcription in response to low energy supply, supporting that activation of AMPK adapts rRNA synthesis to nutrient availability and the cellular energy status.
AMPK ͉ glucose deprivation ͉ RNA polymerase I ͉ TIF-IA ͉ transcription T he maintenance of cellular energy levels in response to changes in nutrient availability, exercise, or stress stimuli is pivotal for cellular homeostasis. Disruption of this balance is associated with a number of pathologies including diabetes, cancer and heart disease. AMP-activated protein kinase (AMPK) plays a crucial role in translating changes in energy levels into adaptive cellular responses (1, 2) . Stimuli that increase the cellular AMP/ATP ratio lead to phosphorylation-dependent activation of AMPK by upstream protein kinases, such as LKB1 and/or the calcium/calmodulin-dependent protein kinase (CaMKK) (3) (4) (5) . AMPK serves important functions in the nucleus, modulating the activity of specific transcriptions factors and coregulators, such as HNF4a (6) , ChRBP (7), p53 (8) , and p27 (9) . Thus, AMPK-dependent phosphorylation provides a direct link between cellular energy metabolism and regulation of gene expression.
Conditions that harm cell growth, including stress, nutrient starvation or toxic lesions, down-regulate transcription of rRNA genes (rDNA), whereas agents that stimulate growth and proliferation upregulate rDNA transcription (10) (11) (12) . TIF-IA, the Pol I-associated transcription factor that transmits external signals to the nucleolar transcription machinery, is targeted by a variety of protein kinases that phosphorylate TIF-IA at multiple sites. For example, increase in pre-rRNA synthesis upon mitogenic stimulation correlates with phosphorylation of TIF-IA at Ser-633 and Ser-649 by ERK and RSK (13) . Moreover, mTORdependent phosphorylation at Ser-44 activates TIF-IA, whereas Thr-200 phosphorylation by JNK2 impairs TIF-IA activity (14, 15) . Given the central function of AMPK in sensing the cellular energy status, we surmised that AMPK-dependent phosphorylation of the Pol I transcription apparatus would be an efficient means to down-regulate rDNA transcription and ribosome biogenesis at low ATP levels. We show that activation of AMPK by glucose deprivation or treatment with the AMP-mimetic drug AICAR (5-amino-4-imidazolecarboxamide ribonucleotide) (16) leads to inactivation of TIF-IA both in vivo and in vitro. AMPK phosphorylates TIF-IA at serine 635 (Ser-635), and this phosphorylation impairs the interaction of TIF-IA with the TBPcontaining promoter selectivity factor SL1. Consequently, recruitment of Pol I to the rDNA promoter and transcription complex formation is impaired. The results decipher a unique connection between the AMPK pathway and the nucleolar transcription machinery, implicating a mechanism that adapts rRNA synthesis to changes in cellular energy supply.
Results

Glucose Deprivation Leads to AMPK-Dependent Repression of Pol I
Transcription. In mammalian cells, glucose deprivation leads to rapid down-regulation of rDNA transcription, the level of prerRNA decreasing by 50-70% within 6 h ( Fig. 1A and Fig. S1 ). Transcription was restored after refeeding with glucose, indicating that inhibition of pre-rRNA synthesis is relieved when normocaloric conditions are reestablished. Consistent with glucose deprivation decreasing the cellular energy charge, ATP levels dropped by 70% (Fig. 1B Upper) . The drop of cellular ATP and concomitant increase in AMP levels triggered phosphorylation-dependent activation of AMPK at Thr-172 (17), suggesting that AMPK down-regulates pre-rRNA synthesis by targeting component(s) of the Pol I transcription machinery (Fig. 1B  Lower) . Indeed, activation of AMPK by AICAR (5-amino-4-imidazolecarboxamide ribonucleotide) (16) treatment caused an even stronger decrease in pre-rRNA synthesis than glucose deprivation ( Fig. 1 B and C) . Although in low glucose Pol I transcription partially recovered, presumably due to AMPKdependent activation of catabolic pathways that refill the ATP pool, Pol I transcription remained repressed after AICAR treatment, supporting the notion that AICAR activates AMPK independent of the cellular energy charge.
To demonstrate that AMPK interferes with Pol I transcription, we pulse-labeled nascent RNA with fluorouridine (FUrd) in the absence or presence of AICAR and visualized FUrdlabeled RNA by indirect immunofluorescence. Consistent with the high transcription rate of rRNA genes, FUrd staining was most pronounced in nucleoli, colocalizing with the basal Pol I transcription factor UBF (Fig. 1D Top) . Nucleolar labeling was abolished after treatment with AICAR, indicating that AMPK abrogated pre-rRNA synthesis (Fig. 1D Middle) . Noteworthy, AICAR treatment induced relocalization of UBF to the nucleolar periphery reminiscent of redistribution of UBF observed in actinomycin D-treated cells (18) . Nucleolar transcription fully recovered after removal of AICAR, demonstrating that repression of Pol I transcription by AMPK is reversible (Fig. 1D  Bottom) .
TIF-IA Rescues Pol I Transcription in Extracts from Glucose-Deprived
Cells. To explore the molecular mechanism underlying AMPKdependent down-regulation of Pol I transcription, we assayed the effect of AMPK on rDNA transcription in vitro. Addition of immunopurified HA-tagged AMPK (Fig. S2 ) to a fractionated nuclear extract inhibited the synthesis of Pol I-specific runoff transcripts in a dose-dependent manner ( Fig. 2A lanes 1-3) , whereas the kinase-deficient mutant HA-AMPK/DN did not affect transcription (Fig. 2 A lanes 4 and 5) .
We then compared the transcriptional activity of nuclear extracts from glucose-deprived and control HEK293T cells. Transcription of the rDNA template was markedly reduced in extracts from glucose-deprived cells (see Fig. 2B ), indicating that AMPK-dependent repression of Pol I transcription can be mimicked in vitro. Importantly, transcriptional repression was overcome by addition of recombinant TIF-IA, demonstrating that glucose deprivation has inactivated TIF-IA ( Fig. 2B lanes  3-5) . In support of this conclusion, TIF-IA from control cells, but not from AICAR-treated cells, restored transcription in extracts from glucose-deprived cells (Fig. 2C) . The levels of individual components of the Pol I transcription apparatus, including TIF-IA, Pol I (RPA116), SL1 (TAF I 110), and UBF, were comparable in both extracts, indicating that neither the synthesis nor stability of these proteins were affected (Fig. 2D) .
AMPK Phosphorylates TIF-IA at Serine 635. TIF-IA is phosphorylated at multiple sites by numerous protein kinases (13) (14) (15) 19) . Group-based phosphosite prediction (http://gps.biocuckoo.org) revealed that Ser-635, a residue conserved within the C-terminal domain of vertebrate TIF-IA (Fig. S3A) , is a putative AMPK target site. In support of AMPK targeting TIF-IA, coimmunoprecipitation experiments revealed that TIF-IA and AMPK interact with each other (Fig. 3A and Fig. S3B ). To examine whether TIF-IA is phosphorylated by AMPK, we monitored phosphorylation of GST-TIF-IA by immunopurified AMPK in vitro. As shown in Fig. 3B , HA-AMPK, but not the kinasedeficient mutant HA-AMPK/DN, was capable to phosphorylate TIF-IA. Substituting Ser-635 by alanine (TIF-IAS635A) compromised phosphorylation, supporting that AMPK targets Ser-635 (Fig. 3B Right) .
To demonstrate AMPK-dependent phosphorylation of Ser-635 in vivo, we metabolically labeled TIF-IA with [ 32 P]orthophosphate in the absence or presence of AICAR, and mapped the tryptic phosphopeptides by electrophoresis and chromatography. Upon stimulation by AICAR, labeling of spot c was markedly enhanced in wild-type but not mutant TIF-IAS635A (Fig. 3C ). Spot c comprises the C-terminal tryptic peptide that harbors Ser-635, Ser-633, and Ser-649 (Fig. S3C ). Ser-633 and Ser-649 are phosphorylated by ERK and RSK, phosphorylation at Ser-635 precluding phosphorylation of Ser-633 and Ser-649 (13) . Therefore, single and multiple phosphorylations at these phosphoacceptor sites give rise to spots c, d, f, and g, peptide c being exclusively phosphorylated at Ser-635 (Fig. S3C) . The different position of spot d in the maps of wild-type and mutant TIF-IA is due to the serine-alanine substitution, which increases the mobility of phosphopeptide d ( which decreases in response to mTOR signaling (14) , was slightly increased after AICAR treatment (Fig. 3C) . Unexpectedly, phosphorylation of Ser-44 (spot b), which is enhanced in response to mTOR signaling, was not decreased upon AMPK activation, indicating that mTOR and AMPK regulate TIF-IA independently. This result is supported by immunoblotting with phosphoSer635-specific antibodies, showing that Ser-635 phosphorylation was strongly enhanced in glucose-deprived and AICAR-treated but not in rapamycin-treated cells (Fig. 3 D 
Phosphorylation of TIF-IA at S635 Impairs Transcription Complex
Formation. TIF-IA plays a key role in transcription initiation complex formation, recruiting Pol I to the transcription start site by association with the preinitiation complex comprising UBF and the TBP-TAF I complex SL1 (22, 23) . We used ChIP to examine whether AMPK-dependent phosphorylation of TIF-IA affects the association of TIF-IA and/or Pol I with rDNA. After glucose deprivation or AICAR treatment, promoter occupancy of Pol I and TIF-IA, but not of UBF and SL1, decreased by Ϸ60%, suggesting that AMPK prevented TIF-IA-dependent recruitment of Pol I (Fig. 5A) . Pol I occupancy at the rDNA coding region dropped accordingly, whereas no change in UBF occupancy was observed ( Fig. S5 and Table S1 ).
To examine whether phosphorylation by AMPK affects the interaction of TIF-IA with Pol I and/or with SL1, we immunoprecipitated Flag-tagged TIF-IA or TIF-IAS635A from untreated, glucose-deprived or AICAR-treated cells, and monitored coprecipitated Pol I (RPA116) on immunoblots. Similar amounts of Pol I were coprecipitated with wildtype and mutant TIF-IA in untreated and treated cells, indicating that phosphorylation of Ser-635 does not impair the association of TIF-IA with Pol I (Fig. 5B) . Likewise, the interaction between Pol I and endogenous TIF-IA was not affected upon glucose-deprivation or AICAR-treatment (Fig. 5C Upper) . In contrast, the association between TIF-IA and SL1 was strongly reduced upon glucose deprivation or AICAR treatment (Fig. 5C Lower) . To prove this observation, we precipitated SL1 from a HeLa cell line that stably expresses Flag-tagged TAF I 110 (24) and monitored coprecipitation of TIF-IA. Again, AICAR treatment abolished the interaction between TIF-IA and SL1 (Fig. 5D ), in accord with AMPK impairing the interaction of TIF-IA with SL1. Consistently, GFP-TIF-IA from glucose-deprived cells was less capable to pull-down partially purified TAF I 68, the second largest subunit of mouse SL1, than GFP-TIF-IA from control cells. GFP-TIF-IAS635A, however, bound to TAF I 68 with similar efficiency, regardless whether it was prepared from control or glucose-deprived cells (Fig. 5E ). These results demonstrate that Ser-635 phosphorylation affects the association of the TIF-IA/ Pol I complex with promoter-bound SL1, thereby abrogating an early and important step in the assembly of productive transcription initiation complexes.
Discussion
It has long been recognized that a given nutritional state affects the cellular equilibrium in which the synthesis of ATP is balanced by its use in protein synthesis and other energy-consuming processes. If energy levels are low and the intracellular AMP/ ATP ratio is elevated, AMPK switches on energy-producing pathways and switches off energy-consuming pathways to restore cellular ATP levels. Therefore, under conditions of nutrient shortage, cells down-regulate energy-consuming processes, like ribosome biogenesis and protein synthesis. At low cellular ATP levels, transcription of rRNA genes decreases, whereas elevated ATP levels enhance rRNA synthesis (25) . AMPK targets multiple proteins ranging from key metabolic enzymes to transcription and translation factors (26) . Here, we show activation of AMPK either by glucose-deprivation or by the AMP-mimetic drug AICAR triggers phosphorylation of TIF-IA at Ser-635, leading to inactivation of TIF-IA, disruption of transcription initiation complexes and inhibition of rRNA synthesis (Fig. 5F ). These results uncover a yet unrecognized mechanism mammalian cells use to couple the cellular energy status to ribosome biogenesis, cell growth, and proliferation.
TIF-IA, the mammalian homolog of yeast Rrn3p (27, 28) , confers most of growth-dependent control of rDNA transcription. Conditions that support growth and proliferation, such as nutrients and growth factors, induce mTOR-and MAPKdependent signaling pathways that activate TIF-IA by phosphorylating specific serine residues (Ser-44, Ser-633, and Ser-649) (13, 14) . Conversely, conditions that harm cell proliferation and activate JNK2, inactivate TIF-IA by triggering phosphorylation at Thr-200 (15) . JNK2-, MAPK-and mTOR-dependent phosphorylation of TIF-IA regulates the interaction of TIF-IA with Pol I, affecting recruitment of Pol I to the rDNA promoter and the formation of productive transcription complexes. In contrast, AMPK-mediated phosphorylation of TIF-IA at Ser-635 does not compromise binding of TIF-IA to Pol I but abrogates the interaction between promoter-bound SL1 and TIF-IA, which also impairs transcription complex assembly. These results uncover another level of Pol I transcriptional regulation, TIF-IA sensing not only external signals but also translating changes of intracellular energy supply into changes of rRNA synthesis. Likewise, in yeast Pol I recruitment to rDNA depends on Rrn3p, the homolog of TIF-IA (28), and is controlled by the TORpathway (29) . Phosphorylation of Pol I, rather than Rrn3p, regulates formation of the Rrn3p/Pol I complex (30) , indicating that yeast and mammals use different mechanisms to regulate Pol I transcription. It will be interesting to learn whether SNF1, the yeast homolog of AMPK that is not activated by AMP (26) , serves a similar function as AMPK, adapting rDNA transcription to the cellular energy status.
AMPK is known to repress mTOR activity by activating TSC2, a negative regulator of mTOR, and by phosphorylation of the mTORC1 component Raptor (20, 21) . Therefore, one would expect that down-regulation of mTOR signaling at low energy supply is sufficient to impair TIF-IA activity. Indeed, phosphopeptide mapping of metabolically labeled TIF-IA revealed that AICAR treatment caused hyperphosphorylation of Ser-199, a residue that is also phosphorylated upon rapamycin-mediated inhibition of mTOR (14) . However, activation of AMPK did not affect phosphorylation of Ser-44, which is dephosphorylated by PP2A upon abrogation of mTOR-signaling (14) . This observa- tion may be explained by the fact that activation of AMPK will compromise PP2A activity in a FOXO3-dependent manner (31, 32) , preventing PP2A-dependent dephosphorylation of Ser-44. Coregulation by mTOR-signaling and AMPK has also been reported for the elongation factor 2 kinase (eEF2K), a negative regulator of eE2F, which is inactivated by mTOR-dependent phosphorylation at Ser-366 (33) and activated by AMPKmediated phosphorylation of Ser-398 (34). Thus, AMPK affects both eE2FK and TIF-IA, key factors required for translation and ribosome biogenesis, ensuring a fine tuned regulation of the cellular protein synthesis machinery in response to nutrient and energy availability. Recently, Murayama et al. (35) have described another mechanism that couples the cellular energy status to repression of rDNA transcription. They have identified a protein complex, energy-dependent Nucleolar Silencing Complex (eNoSC), which contains the NAD ϩ -dependent histone deacetylase SIRT1, the heterochromatic histone methyltransferase SUV39H1, and Nucleomethylin (NML), a nucleolar protein that specifically binds to the heterochromatic histone mark H3K9me2. eNoSC changes the ratio of active to silent rRNA genes in response to the cellular energy status. Upon prolonged glucose depletion, increased NAD ϩ levels activate SIRT1 and SUV39H1, which in turn trigger heterochromatin formation and transcriptional silencing. Thus, cells use at least two mechanisms to downregulate nucleolar activity according to the overall level of energy supply, a fast response involving AMPK-dependent inactivation of TIF-IA and a slow response involving SIRT1-and SUV39H1-dependent epigenetic regulation.
Materials and Methods
Cell Culture, Transfection, Retroviral Infection, and RNA Analysis. Cells were cultured in DMEM containing 25 mM glucose and 10% FCS. For glucose deprivation, cells were transferred to glucose-free DMEM. Transfection was performed using the calcium phosphate-DNA coprecipitation method. Infection of NIH 3T3 cells was carried out with pBabe based retroviruses encoding Flag-TIF-IA and TIF-IAS635A. Cellular pre-rRNA and ␤-actin mRNA was analyzed on Northern blots using specific riboprobes. Alternatively, pre-rRNA levels or reporter gene transcripts were measured by reverse transcription using random hexamer primers and quantitative real-time PCR. Data were normalized to the level of ␤-actinmRNA. Primer sequences are given in Table S2 .
FUrd Labeling of Nascent RNAs and Immunofluorescence. Cells grown on coverslips were labeled with 2 mM fluorouridine (FUrd) for 15 min. Cells were fixed in 2% para-formaldehyde, permeabilized with methanol at Ϫ20°C, and incubated with ␣-BrU and ␣-UBF antibodies, followed by incubation with the appropriate secondary antibodies coupled to Cy3 or FITC.
Extract Preparation and In Vitro Transcription. Nuclear extracts were prepared from HEK293T cells grown in glucose-rich or -free DMEM. In vitro transcription assays contained 40 g of nuclear extract or 15 g of nuclear extract fractionated on a DEAE-column (280 mM KCl elution step) and 40 ng of template pHrP 2 linearized with NdeI. To assay TIF-IA activity, 10 -50 ng of immunopurified Flag-TIF-IA expressed in HEK293T cells were added. The amount and purity of Flag-TIF-IA was monitored on silver-stained polyacrylamide gels. ChIP, Immunoprecipitation, and Pull-Down. ChIP assays were performed as described in ref. 
